(18.117.108.171)
Users online: 5350     
Ijournet
Email id
 

Asian Journal of Nursing Education and Research
Year : 2023, Volume : 13, Issue : 3
First page : ( 226) Last page : ( 227)
Print ISSN : 2231-1149. Online ISSN : 2349-2996.
Article DOI : 10.52711/2349-2996.2023.00048

Spravato (Esketamine)

Nirosha V.1,*, Gayathri V.2

1Associate Professor, Vivekanandha College of Nursing, Tiruchengode, Namakkal

2Nursing Tutor, Vivekanandha College of Nursing, Tiruchengode, Namakkal

*Corresponding Author Email: niroshanbalagan@gmail.com

Online Published on 30 September, 2023.

Abstract

Depression is more than feeling a little sad or "blue" for a few days. Antidepressant medications are used in the treatment of clinical depression, usually alongside other forms of therapy such as psychological or behavioral therapy. Spravato is a medicine used to treat adults with major depression that is resistant to treatment. (Bahr, 2019) It is used in combination with an SSRI or SNRI medicine (other antidepressants) when at least two other treatments have failed. Spravato contains the active substance esketamine.

Top

Keywords

Depression, Antidepressants, Antagonist, Bioavailability, Hyperhidrosis, Glucuronidation, Pollakiuria, Dysgeusia.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
750,942,148 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.